Results 131 to 140 of about 10,746 (218)

Evidence-based drug therapy in the management of heart failure [PDF]

, 2011
This article provides an update on the drug treatment for heart failure (HF) mostly based on the recent clinical guidelines issued by the National Institute of Clinical Excellence (NICE).1 New high quality evidence from randomised controlled trials has ...
Gauci, Marise
core  

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT

Российский кардиологический журнал, 2009
Aim. To investigate effectiveness and safety of trimetazidine MB in the complex treatment of stable angina. In total, 90 patients were examined – 57 women and 33 men aged 48-70 years (mean age 61,4 ± 6,03 years).
N. A. Shostak, O. G. Smolenskaya, A. V. Panov, A. A. Klimenko, D. Yu. Andriyashkina, N. A. Tverdova   +5 more
doaj  

Pathophysiological aspects and clinical outcome of intra-anal application of isosorbide dinitrate in patients with chronic anal fissure. [PDF]

, 1996
W. R. Schouten, J. W. Briel, Michiel O. Boerma, Johannes J.A. Auwerda, Ellen Wilms, B. H. Graatsma   +5 more
openalex   +1 more source

Health technology review : the efficacy and effectiveness of sustained release oral nitroglycerin in comparison to regular delivery isosorbide dinitrate for the prophylactic treatment of stable angina pectoris

, 2014
Ken Bassett, M.L. Rhone
openalex   +1 more source

A Comparison of Enalapril with Hydralazine–Isosorbide Dinitrate in the Treatment of Chronic Congestive Heart Failure [PDF]

, 1991
Jay N. Cohn, Gary R. Johnson, Susan Ziesche, Frederick R. Cobb, Gary S. Francis, Felix E. Tristani, Raphael F. Smith, W. Bruce Dunkman, Henry S. Loeb, Maylene Wong, Geetha Bhat, Steven Goldman, Ross D. Fletcher, James E. Doherty, C. V. Hughes, Peter E. Carson, Guillermo Cintrón, Ralph Shabetai, Clair Haakenson   +18 more
openalex   +1 more source

Validation of pressure gradient and peripheral fractional flow reserve measured by a pressure wire for diagnosis of iliofemoral artery disease with intermediate stenosis

Medical Devices: Evidence and Research, 2015
Naotaka Murata,1 Hideaki Aihara,2 Yoshimitsu Soga,1 Yusuke Tomoi,1 Seiichi Hiramori,1 Yohei Kobayashi,1 Kei Ichihashi,1 Nobuhiro Tanaka3 1Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, 2Department of Cardiology, Tsukuba Medical Center ...
Murata N, Aihara H, Soga Y, Tomoi Y, Hiramori S, Kobayashi Y, Ichihashi K, Tanaka N   +7 more
doaj  

Simultaneous Equation Method and Absorption Correction Method for the Estimation of Isosorbide Dinitrate and Hydalazine Hydrochloride in Bulk and Their Combined Tablet Dosage Form using UV Spectrophotometry.

, 2015
S.K. Mastannama, T. Ananta Sridhar
openalex   +1 more source

Vasodilator Properties of Nitroglycerin, Isosorbide Dinitrate and Chlorpromazine during Cardiopulmazine during Cardiopulmonaty Bypass [PDF]

, 1995
Geu Jeung Yang, Seung Hwan Bae, Chan Jong Chung, Young Jhoon Chin   +3 more
openalex   +1 more source

The DANish randomized, double-blind, placebo controlled trial in patients with chronic HEART failure (DANHEART): A 2 × 2 factorial trial of hydralazine-isosorbide dinitrate in patients with chronic heart failure (H-HeFT) and metformin in patients with chronic heart failure and diabetes or prediabetes (Met-HeFT). [PDF]

Am Heart J, 2021
Wiggers H, Køber L, Gislason G, Schou M, Poulsen MK, Vraa S, Nielsen OW, Bruun NE, Nørrelund H, Hollingdal M, Barasa A, Bøttcher M, Dodt K, Hansen VB, Nielsen G, Knudsen AS, Lomholdt J, Mikkelsen KV, Jonczy B, Brønnum-Schou J, Poenaru MP, Abdulla J, Raymond I, Mahboubi K, Sillesen K, Serup-Hansen K, Madsen JS, Kristensen SL, Larsen AH, Bøtker HE, Torp-Petersen C, Eiskjær H, Møller J, Hassager C, Steffensen FH, Bibby BM, Refsgaard J, Høfsten DE, Mellemkjær S, Gustafsson F.   +39 more
europepmc   +1 more source

ORGANIC NITRATE CHOICE IN ANTIANGINAL THERAPY OF STABLE ANGINA PECTORIS

Российский кардиологический журнал, 2011
Aim. To assess the use of isosorbide-5-mononitrate in clinical practice and evaluate its benefits in antianginal therapy of stable angina pectoris, based on pharmaco-economic analysis data. Material and methods. The authors analysed 902 medical histories
E. V. Solyanik, E. V. Eliseeva, B. I. Geltser, E. V. Yakukhnaya   +3 more
doaj